GAGhaidaa Raheem Lateef Al-Awsi

Ghaidaa Raheem Lateef Al-Awsi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ghaidaa Raheem Lateef Al-Awsi has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    CircRNAs and lncRNAs in Allergic Rhinitis: Mechanisms and Therapeutic Insights

    by Elham Mohammadisoleimani, Abbas Shahi, Ghaidaa Raheem Lateef Al-Awsi, Zahra Firoozi, Farshad Dehghani, Hosein Mansoori, Ali Moravej, Yaser Mansoori

    Allergic rhinitis (AR) is a nasal inflammatory disease that affects people all across the world and has a high prevalence rate, with estimates suggesting it affects up to 20%–40% of the population. Its underlying processes regarding the control of the innate immune response remain unknown. Understanding the underlying immunological systems is the key to creating more effective and precise therapies. Both long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) have complex functional processes. Briefly, lncRNAs are found in the nucleus and the cytoplasm. They may interact with chromatin complexes, regulatory proteins, and enzyme cofactors, bind DNA/RNA‐binding proteins (RBPs), and can also act as sponges of microRNAs (miRNAs). A new family of endogenous ncRNA is called circRNAs that are stable and conserved. Unlike linear RNA, circRNA is a kind of single‐stranded RNA that forms a covalently closed continuous loop. CircRNAs have a crucial function in the regulation of inflammatory disorders. This review focuses primarily on new investigations of the function, regulatory mechanism, and therapeutic potential of ncRNAs, particularly lncRNA and circRNA, in AR.

  • Open Access

    Application of nano-antibiotics in the diagnosis and treatment of infectious diseases

    by G. R. L. Al-Awsi, A. A. Alameri, A. M. B. Al-Dhalimy, G. A. Gabr, E. Kianfar

    Infectious diseases are the leading cause of death worldwide. Thus, nanotechnology provides an excellent opportunity to treat drug-resistant microbial infections. Numerous antibiotics have been used to inhibit the growth and kill of microbes, but the development of resistance and the emergence of side effects have severely limited the use of these agents. Due to the development of the nanotechnology, nanoparticles are widely used as antimicrobials. Silver and chitosan nanoparticles have antifungal, antiviral and antibacterial properties, and many studies confirm the antifungal properties of silver nanoparticles. Nowadays, the use of nanoparticles in the diagnosis and treatment of infectious diseases has developed due to less side effects and also the help of these particles in effective drug delivery to the target tissue. Liposomes are also used as carriers of drug delivery, genes, and modeling of cell membranes in both animals and humans. The ability of these liposomes to encapsulate large amounts of drugs, minimize unwanted side effects, high effectiveness and low toxicity has attracted the interest of researchers. This review article examines recent efforts by researchers to identify and treat infectious diseases using antimicrobial nanoparticles and drug nano-carriers.


  • Open Access

    Genetic Diversity among Pseudomonas aeruginosa Isolated From Different Sources in Al-Diwaniyah City, Iraq Using RAPD-PCR Technique

    by Ghaidaa Raheem Lateef Al-Awsi, Ali A Alsudani, Saja Mahdy Jabir, Mohammed Al-Mudhaffar

    Pseudomonas aeruginosa is an aerobic Gram-negative bacterium which has emerged as one of the most problematic nosocomial pathogens. To characterizes P. aeruginosa strains that are widespread in patients in Al-Diwaniyah city, 30 clinical and environment samples were collected from general hospitals of Al-Diwaniyah city. Methods for isolation and identifying P. aeruginosa based upon culture methods coupled with biochemical tests, A total of 11 amplified DNA fragments ranging in size from 250 to 1 Kpb were observed using two random amplified polymorphic DNA (RAPD) primers (opX-13, op Y-04) where as22 polymorphic amplified fragments were commonly detected among the 6 p. aeuroginosa isolates and each of primer give different genetic profiles. The results shows the RAPD-PCR analysis is a good epidemiological screening method to detect genetic variation among pseudomonas aeuroginosa isolates.

  • Open Access

    In vitro, the Antimicrobial activity of some medicinal plant extracts on the growth of some bacterial and fungal pathogens

    by Ali A Alsudani, Ghaidaa J Mohammed, Ghaidaa Raheem Lateef Al-Awsi

    This study was done during the period between October to December 2018. The antimicrobial activity of ethanolic extracts of some medicinal plants Daucus carota (seeds), Rheum ribes (roots), Rumex vesicarius (leaves) and Punica granatum (peels) were tested against some clinical isolate of Gram-negative bacteria (Proteus mirabilis, Helicobacter pylori and Klebsiella pneumonia), Gram-positive bacteria (Staphylococcus epidermidis and Streptococcus mutans) and against some pathogenic fungi Trichophyton violaceum and Microsporum audouinii that get from Al-Diwaniyah teaching hospital. The result showed P. granatum have the highest antibacterial activity against all bacterial isolates under study than other extracts, the diameters ranged between (24.4-31.3) mm followed with the D. carota extracts which the diameters ranged between (20.4-28.5) mm, also the result obtained that the most inhibition percentage against fungal isolates was with P. granatum extract which ranged between (64.5-68.6) %, followed with D. carota extract which ranged between (60.7-63.4) %.